Karim Fekir

Senior Scientist at Sanofi Belgique
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Ghent, Flemish Region, Belgium, BE
Languages
  • Français Native or bilingual proficiency
  • Anglais Full professional proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Belgium
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Senior Scientist
      • Apr 2022 - Present

    • France
    • Biotechnology Research
    • 1 - 100 Employee
    • Scientist
      • Aug 2019 - Mar 2022

      We are specialized in screening using multiple cellular models to provide early access to the therapeutic potential of a molecule. We are specialized in screening using multiple cellular models to provide early access to the therapeutic potential of a molecule.

    • United Kingdom
    • Research Services
    • 700 & Above Employee
    • Postdoctoral Research Scientist
      • Jun 2016 - Aug 2019

      My research focused on the characterisation of relevant cells population which are able to contribute to the repair process and understanding how these cells can be used as part of novel interventions and therapy for the clinic. My research focused on the characterisation of relevant cells population which are able to contribute to the repair process and understanding how these cells can be used as part of novel interventions and therapy for the clinic.

    • France
    • Research Services
    • 700 & Above Employee
    • PhD
      • Oct 2011 - May 2015

      My PhD was entitled “Biomarkers and new therapeutic approaches targeting cancer stem cells in hepatocellular carcinoma” supervised by Dr Anne Corlu in Inserm U991 “Liver, metabolism and cancer” laboratory. In my thesis, we identified molecular effectors involved in the acquisition and maintenance of stem cells features using transcriptomic analysis and 3D models of liver cancer stem cells. We showed that cancer stem cells develop mechanisms that modulate inflammatory response, redox homeostasis and metabolic functions that contribute to chemoresistance. We also demonstrated that restoration of mitochondrial activity in combination with chemotherapy could represent a useful therapeutic approach to target cancer stem cells. In another work, we previously shown that inflammatory environment promoted the retrodifferentiation of hepatocytes into progenitors cells using transcriptomic analysis. All my research experiences give me a strong background in stem cells, transcriptomics and tumor biology. Show less

Education

  • Université de Rennes 1
    Doctor of Philosophy - PhD, Molecular and cell biology
    2011 - 2015
  • Université Paris-Sud
    Master's degree, Biotechnology
    2009 - 2011

Community

You need to have a working account to view this content. Click here to join now